NYSE:INFU InfuSystem (INFU) Stock Price, News & Analysis $10.78 +0.05 (+0.47%) Closing price 04:00 PM EasternExtended Trading$10.78 0.00 (-0.05%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About InfuSystem Stock (NYSE:INFU) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get InfuSystem alerts:Sign Up Key Stats Today's Range$10.56▼$11.0450-Day Range$5.41▼$10.7852-Week Range$4.61▼$11.04Volume314,045 shsAverage Volume176,357 shsMarket Capitalization$220.19 millionP/E Ratio179.70Dividend YieldN/APrice Target$12.50Consensus RatingStrong Buy Company Overview InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan. Read More InfuSystem Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks46th Percentile Overall ScoreINFU MarketRank™: InfuSystem scored higher than 46% of companies evaluated by MarketBeat, and ranked 620th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingStrong Buy Amount of Analyst CoverageInfuSystem has only been the subject of 1 research reports in the past 90 days.Read more about InfuSystem's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth106.67% Earnings GrowthEarnings for InfuSystem are expected to grow by 106.67% in the coming year, from $0.15 to $0.31 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InfuSystem is 179.70, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 63.63.Price to Earnings Ratio vs. SectorThe P/E ratio of InfuSystem is 179.70, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 31.45.Price to Book Value per Share RatioInfuSystem has a P/B Ratio of 4.36. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.77% of the float of InfuSystem has been sold short.Short Interest Ratio / Days to CoverInfuSystem has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in InfuSystem has recently decreased by 15.32%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInfuSystem does not currently pay a dividend.Dividend GrowthInfuSystem does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.77% of the float of InfuSystem has been sold short.Short Interest Ratio / Days to CoverInfuSystem has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in InfuSystem has recently decreased by 15.32%, indicating that investor sentiment is improving significantly. News and Social Media2.6 / 5News Sentiment0.63 News SentimentInfuSystem has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for InfuSystem this week, compared to 1 article on an average week.Search InterestOnly 2 people have searched for INFU on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows5 people have added InfuSystem to their MarketBeat watchlist in the last 30 days. Company Ownership3.3 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, InfuSystem insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $55,622.00 in company stock.Percentage Held by Insiders11.40% of the stock of InfuSystem is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions71.13% of the stock of InfuSystem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about InfuSystem's insider trading history. Receive INFU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INFU Stock News HeadlinesInfuSystem (NYSE:INFU) Director Sells $55,621.84 in StockAugust 23, 2025 | insidertrades.comInfuSystem: A New Sheriff In TownAugust 26 at 3:19 PM | seekingalpha.com$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.August 29 at 2:00 AM | Brownstone Research (Ad)InfuSystem Holdings Reports Mixed Earnings Call ResultsAugust 5, 2025 | tipranks.comInfuSystem (INFU) Q2 EPS Jumps 300%August 5, 2025 | fool.comInfuSystem raises adjusted EBITDA margin outlook to 20%+ as margin expansion continues amid revenue guide revisionAugust 5, 2025 | msn.comInfuSystem Holdings, Inc. (INFU) Q2 2025 Earnings Call TranscriptAugust 5, 2025 | seekingalpha.comInfuSystem Reports Second Quarter 2025 Financial ResultsAugust 5, 2025 | businesswire.comSee More Headlines INFU Stock Analysis - Frequently Asked Questions How have INFU shares performed this year? InfuSystem's stock was trading at $8.45 at the beginning of the year. Since then, INFU shares have increased by 27.6% and is now trading at $10.78. How were InfuSystem's earnings last quarter? InfuSystem Holdings, Inc. (NYSE:INFU) posted its earnings results on Thursday, November, 7th. The company reported $0.08 earnings per share for the quarter, hitting the consensus estimate of $0.08. The business had revenue of $35.32 million for the quarter, compared to the consensus estimate of $35.50 million. InfuSystem had a trailing twelve-month return on equity of 2.78% and a net margin of 1.12%. Who are InfuSystem's major shareholders? Top institutional shareholders of InfuSystem include AWM Investment Company Inc. (6.23%), Minerva Advisors LLC (4.87%), First Eagle Investment Management LLC (4.33%) and Geode Capital Management LLC (1.06%). Insiders that own company stock include Richard Dilorio, Carrie Lachance, Christopher R Sansone, Scott Shuda, Barry G Steele, Paul Andrew Gendron, R Rimmy Malhotra, Addam Chupa, Kenneth D Eichenbaum, Ralph F Boyd Jr, Kevin Whitman and Gregg Owen Lehman. View institutional ownership trends. How do I buy shares of InfuSystem? Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of InfuSystem own? Based on aggregate information from My MarketBeat watchlists, some other companies that InfuSystem investors own include Advanced Micro Devices (AMD), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), Home Depot (HD), JPMorgan Chase & Co. (JPM) and Netflix (NFLX). Company Calendar Last Earnings11/07/2024Today8/29/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNYSE:INFU Previous SymbolNYSE:INFU CIK1337013 Webwww.infusystem.com Phone(248) 291-1210Fax800-455-4338Employees410Year FoundedN/APrice Target and Rating Average Price Target for InfuSystem$12.50 High Price Target$13.00 Low Price Target$12.00 Potential Upside/Downside+16.0%Consensus RatingStrong Buy Rating Score (0-4)4.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)$0.23 Trailing P/E Ratio179.60 Forward P/E Ratio71.87 P/E GrowthN/ANet Income$870 thousand Net Margins1.12% Pretax Margin2.65% Return on Equity2.78% Return on Assets1.41% Debt Debt-to-Equity Ratio0.50 Current Ratio1.98 Quick Ratio1.59 Sales & Book Value Annual Sales$139.89 million Price / Sales1.57 Cash Flow$0.84 per share Price / Cash Flow12.79 Book Value$2.47 per share Price / Book4.36Miscellaneous Outstanding Shares20,426,000Free Float19,095,000Market Cap$220.19 million OptionableOptionable Beta1.81 Social Links The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NYSE:INFU) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InfuSystem Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InfuSystem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.